-
Factitious Disorder Imposed on Another mimicking a Dopamine Dysregulation Syndrome
-
Factors Affecting Mortality in Late Stage Parkinson’s Disease
-
Factors associated with dyskinesia in Parkinson’s disease in Mainland China
-
Factors Influencing Decision-Making About End of Life Care in Patients With Parkinson’s Disease and Their Family Members
-
Factors that interfere in the functionality according to Functional Independence Measure in people with Parkinson’s Disease.
-
Factors underlying reduced aerobic capacity in Huntington disease
-
Fall History and Gait Variability can Predict Falls in Individuals With Parkinson’s Disease
-
Familial Creutzfeldt-Jakob disease with D178N and Met129Val
-
Fatal evolution of cutaneous necrosis in a patient treated with subcutaneous apomorphine infusions
-
Fatigue in Parkinson’s Disease
-
Fatigue in Parkinson’s disease and its relation with disease duration and treatment
-
FDG PET: a good predictive tool for CNS inflammation
-
Feasibility and acceptability of a therapist-delivered physical activity coaching intervention for people with premanifest and early stage Huntington’s Disease and Parkinson’s Disease
-
Features of neural activity of globus pallidus in a patient with cervical dystonia and putaminal stroke: case study
-
Ferroptosis, a recently identified cell death, as a therapeutic target for Parkinson’s disease.
-
Fine-mapping of SNCA variants in REM sleep behavior disorder identifies distinct associations
-
Firing pattern of single neurons in the subthalamic nucleus of Tourette Syndrome patients identifies optimal deep brain stimulation target site
-
First Experience with MR-guided Focused Ultrasound in the Treatment of X-linked Dystonia-Parkinsonism (XDP)
-
First year of Opicapone for Advanced Parkinson Disease: real-life experience in a single Movement Disorders Unit
-
First-In-Human Study of LY3154207, a Dopamine D1 Receptor Positive Allosteric Modulator (D1PAM)
-
Fixation suppression the easy way – when nothing else matters
-
Focus on the Locus: Ultra-high field MRI evaluation of locus coeruleus structure and function in Parkinson’s Disease
-
Formulations and evaluations of Intranasal Nose to Brain Delivery of Curcumin with resveratrol Nanoparticle for treatment of Parkisonism
-
Four square step test in patients with early de novo Parkinson’s disease
-
Four-Week Trunk-Specific Exercise Program decreases Forward Trunk Flexion in Parkinson’s disease: a single- blinded, randomized controlled trial
-
Fractional anisotropy patterns in non-demented Parkinson’s disease patients using hierarchical cluster analysis
-
Fragile X Gray Zone Alleles in Men are associated with Parkinsonism
-
Fragile X syndrome presenting with levodopa unresponsive parkinsonism
-
Frailty in Parkinson’s disease: A systematic review
-
Frailty status predicts falls in early Parkinson’s disease
-
Freezer or non-freezer: what is in between?
-
Freezing of gait as a reflection of disturbed general time processing in Parkinson’s disease? A new look on a complex phenomenon
-
Freezing of Gait in Parkinson’s Disease: Risk Factors and Associated Nonmotor Symptoms
-
Freezing of gait in Parkinson’s disease: a review of current neuroimaging evidence for the development of effective therapies
-
Frequency and pattern of movement disorders in a Neurologic clinic in North Central Nigeria: a 3- year review
-
Frequency of Cardiovascular Abnormalities in Mexican Patients with Early Parkinson´s Disease
-
Frequency of impulse control disorder in Parkinson’s disease: insights from the Luxembourg cohort
-
Frequency of neuropsychiatric symptoms in non-demented early and late-onset Parkinson’s disease patients
-
Frequency of PD Non-Motor symptoms in healthy factory workers
-
Frequency-dependent abnormalities of intrinsic brain activity in Parkinson´s disease
-
Frequency, course and predictors of fatigue in Parkinson’s disease patients and population-based controls
-
Functional and dysfunctional impulsivities changes after deep brain stimulation of the subthalamic nucleus
-
Functional Biomarkers of Parkinson’s Disease: Changes in Brain-Wide Network Connectivity in Default Mode and Fronto-Parietal Control Networks
-
Functional Bowel Symptoms in Parkinson´s Disease
-
Functional brain connectome in drug-naïve Parkinson’s disease patients
-
Functional Capacity in patients with Parkinson’s Disease are related to advanced glycation end-products
-
Functional connectivity and microstructural alterations in regions of synaptic density loss in DLB and PDD
-
Functional connectivity within the cerebellum and brainstem in essential tremor patients– a tailored resting state fMRI approach
-
Functional connectome in Parkinson’s disease mild cognitive impairment
-
Functional exam findings in Lewy Body Disease
-
Functional Limits of Stability and Standing Balance in people with and without Freezing of Gait
-
Functional magnetic-resonant imaging in child cerebral palsy with epilepsy
-
Functional mobility tests and their relationship with disease stage in patients with Parkinson’s Disease
-
FUNCTIONAL MOTOR SYMPTOMS IN PARKINSON’S DISEASE, AND FUNCTIONAL PARKINSONISM: A SYSTEMATIC REVIEW
-
Functional MRI activation during the Symbol Digit Modalities Test in Parkinson’s disease
-
Functional Proteomic Analysis of Leukocytes from Parkinson’s Disease Patients: A Clinical Perspective on Biomarkers Identification
-
Functional stiff person like disorders: clinical features and red flags
2019 International Congress
September 22-26, 2019. Nice, France.